Blepharospasm: Clinical Trials

2 trials for Blepharospasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Blepharospasm: new trials by email Literature Review of Blepharospasm trials Research Report on Blepharospasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm
Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops - Dry Eye Disease
Phase 1 / Phase 2UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine122023-03-012023-02-22
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
Acetyl-Hexapeptide Topical Treatment, placebo - Focal Dystonia
Phase 1 / Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)242009-07-012012-09-06

Narrower conditions

Dry Eye Syndromes (1)  ·  Dystonia (1)  ·  Dystonic Disorders (1)

Broader conditions

Eye Diseases (2)  ·  Eyelid Diseases (2)  ·  Central Nervous System Diseases (1)  ·  Dyskinesias (1)  ·  Lacrimal Apparatus Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Ophthalmic Solutions (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (1)  ·  United States (1)

Top investigators

Juan Ye, Doc. (1)

Results publications

PMID 39839752